Malaysia healthcare sector in good shape

Spillover effects from public and private-sector procurement of medication and treatments likely to continue to benefit pharmaceutical players such as Duopharma Biotech and Kotra Industries, says RHB Research.

PETALING JAYA: The recovery of the healthcare sector in Malaysia is expected to gain further traction over the medium term amid further easing of Covid-19 restrictions.

Hospital service providers, for instance, are witnessing an increase in the number of patients, particularly tourist patients, following the reopening of international borders.